Discovery of new IO Targets Leveraging CRISPR

Discovery of new IO Targets Leveraging CRISPR

kidneycancer

2 weeks
15 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Arlene Sharpe M.D. Ph.D. Department of Immunology Harvard Medical School presents Discovery of new IO Targets Leveraging CRISPR Filmed at the 18th International Kidney Cancer Symposium 2019, Miami, FL.

Up Next Autoplay
Treatment-Free Survival, With and Without Toxicity
Treatment-Free Survival, With and Without Toxicity
Category: Kidney Cancer
8 Views
kidneycancer 22 hours
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Category: Kidney Cancer
0 Views
kidneycancer 23 hours
What's To Come in Modern Imaging Technology
What's To Come in Modern Imaging Technology
Category: Kidney Cancer
3 Views
kidneycancer 1 day
Modern Imaging Technology
Modern Imaging Technology
Category: Kidney Cancer
9 Views
kidneycancer 2 days
Management of Clinical Cases in Kidney Cancer
Management of Clinical Cases in Kidney Cancer
Category: Kidney Cancer
10 Views
kidneycancer 3 days
Kidney Cancer Program & SPORE
Kidney Cancer Program & SPORE
Category: Kidney Cancer
8 Views
kidneycancer 3 days
Front Line TKI Based Treatment For Non-Clear Cell RCC
Front Line TKI Based Treatment For Non-Clear Cell RCC
Category: Kidney Cancer
31 Views
kidneycancer 1 week
Consolidative Surgery in the IO Era @WinshipAtEmory
Consolidative Surgery in the IO Era @WinshipAtEmory
Category: Kidney Cancer
16 Views
kidneycancer 1 week
Management of Small Renal Masses @RutgersCancer @eric_facs
Management of Small Renal Masses @RutgersCancer @eric_facs
Category: Kidney Cancer
19 Views
kidneycancer 1 week
Cystic Renal Mass Treatment
Cystic Renal Mass Treatment
Category: Kidney Cancer
16 Views
kidneycancer 1 week